• June 3-6, 2024
  • San Diego Convention Center, California


Tom Pike

Tom Pike

Chairman and Chief Executive Officer
Thomas Pike is Chairman and Chief Executive Officer of Fortrea (Nasdaq: FTRE). He has served in this position since Fortrea’s launch as an independent company in July 2023. Tom joined the organization as President and Chief Executive Officer in January 2023 during Fortrea’s spinoff from its parent company, Labcorp (NYSE: LH). Tom has more than 30 years of leadership experience in global services industries, most notably in the contract research organization (CRO) industry, working with pharmaceutical, biotech, hospitals and sites on a global basis. Prior to joining Labcorp, he co-founded, advised and served as a director for several healthcare and technology services companies. Previously, Tom served as CEO and a member of the Board of Directors of Quintiles Transnational Holdings, Inc. (NYSE: Q), a leading fully integrated biopharmaceutical services company, from April 2012 until its merger with IMS Health in 2016 to create IQVIA (NYSE: IQV). He led Quintiles through its successful IPO, which was one of the year’s 10 largest U.S. offerings, and helped it grow into a Fortune 500 company. Under Tom’s stewardship, Quintiles was first recognized as a World’s Most Admired Company by Fortune in 2015 and was named a 2016 World’s Most Ethical Company. He retired in 2016 as Vice Chairman of the merged Quintiles and IMS. Prior to Quintiles, Tom spent 22 years at Accenture (NYSE: ACN), a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations, until 2009. At Accenture, his roles included Chief Risk Officer and Managing Director of the North America Health and Products business areas. Previously, Tom was the global Chief Operating Officer for Accenture’s Resources operating group and had also served as Accenture’s Chief Strategy Officer. After leaving Accenture in 2009 and until joining Quintiles in 2012, he was involved with a number of start-ups in the technology and healthcare sectors. Early in his career, Tom was a consultant at McKinsey & Company. Tom earned his bachelor's degree in accounting from the University of Delaware. He is a member of the Board of Directors for Martin Marietta Materials, Inc. (NYSE:MLM) having served since 2019.
Speaking In


Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.